What is a common treatment option for genitourinary syndrome of menopause?

Topical estrogen, lubricants, and moisturizers are indeed a common treatment option for genitourinary syndrome of menopause (GSM). This condition is characterized by symptoms such as vaginal dryness, irritation, and discomfort due to decreased estrogen levels after menopause.

Topical estrogen therapies work effectively by targeting local tissues, helping to restore vaginal moisture, elasticity, and overall health of the vaginal and urinary epithelium. This localized treatment minimizes systemic absorption and allows for direct relief of symptoms, making it particularly beneficial for women who may not be candidates for systemic hormone replacement therapy or who prefer an alternative approach.

The use of lubricants and moisturizers also plays a vital role in providing immediate relief from discomfort during sexual activity and in everyday life, complementing topical estrogen in managing GSM symptoms.

Other treatment options, such as systemic anti-inflammatory medications, antibiotics, and antifungals, do not directly address the root causes of GSM related to estrogen deficiency. Similarly, while hormone replacement therapy can be helpful in treating menopausal symptoms more broadly, it is not always the first line for managing local urogenital symptoms, especially when non-systemic treatments are available and effective.